BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4345633)

  • 1. [Combined dexamethasone suppression and chorionic gonadotrophin stimulation test in the diagnosis of androgenic functional ovarian tumors].
    Lehmann WD; Lauritzen C
    Geburtshilfe Frauenheilkd; 1972 Nov; 32(11):913-21. PubMed ID: 4345633
    [No Abstract]   [Full Text] [Related]  

  • 2. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-1969.
    N Engl J Med; 1969 Feb; 280(8):438-44. PubMed ID: 4303133
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hirsutism].
    Laatikainen T
    Duodecim; 1975; 91(7):483-90. PubMed ID: 166814
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of virilizing ovarian tumors and surgical tactics for their treatment].
    Lemeneva ZL; Pishchulin AA; Dobracheva AD; Zheldak LA
    Probl Endokrinol (Mosk); 1977; 23(4):47-52. PubMed ID: 198766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional tumors of the ovary].
    Salvati A
    Minerva Ginecol; 1972; 24(8):429-32. PubMed ID: 4368142
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrastructure of a human chorionic gonadotropin-and adrenocorticotropin-responsive functioning Sertoli-Leydig cell tumor (type I).
    Kalderon AE; Tucci JR
    Lab Invest; 1973 Jul; 29(1):81-9. PubMed ID: 4353887
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW; McEvoy D; Wallach EE
    Obstet Gynecol; 1971 Feb; 37(2):211-7. PubMed ID: 5539356
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhenoblastoma associated with adrenal androgenic hyperfunction.
    Cruikshank DP; Yannone ME; Chapler FK
    Obstet Gynecol; 1974 Apr; 43(4):535-8. PubMed ID: 4361441
    [No Abstract]   [Full Text] [Related]  

  • 9. Ovarian hilus-cell tumours: their varying presentations.
    Salm R
    J Pathol; 1974 Jun; 113(2):117-27. PubMed ID: 4371065
    [No Abstract]   [Full Text] [Related]  

  • 10. Androgen studies in a patient with lipoid-cell tumor of the ovary.
    Osborn RH; Bradbury JT; Yannone ME
    Obstet Gynecol; 1969 May; 33(5):666-72. PubMed ID: 4305119
    [No Abstract]   [Full Text] [Related]  

  • 11. Individual 17-ketosteroid excretion in a case of arrhenoblastoma and its response to corticotrophin and human chorionic gonadotrophin stimulation and to dexamethasone inhibition.
    Louros NC; Batrinos ML; Carcatzoulis S
    J Clin Endocrinol Metab; 1966 Jun; 26(6):645-50. PubMed ID: 4287988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endocrine functional ovarian tumor].
    Tamaya T
    Nihon Rinsho; 2006 Jun; Suppl 2():361-5. PubMed ID: 16817422
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma steroids in two subjects with ovarian androgen-producing tumors arrhenoblastoma and gynandroblastoma.
    Laatikainen T; Pelkonen R; Vihko R
    J Clin Endocrinol Metab; 1972 Mar; 34(3):580-5. PubMed ID: 4334770
    [No Abstract]   [Full Text] [Related]  

  • 14. Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist.
    Lamberts SW; Timmers JM; Oosterom R; Verleun T; de Jong FH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):450-4. PubMed ID: 6274906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative localization of a testosterone-secreting ovarian tumor by retrograde venous catheterization and selective sampling.
    Judd HL; Spore WW; Talner LB; Rigg LA; Yen SS; Benirschke K
    Am J Obstet Gynecol; 1974 Sep; 120(1):91-6. PubMed ID: 4276926
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endocrine studies in a case of arrhenoblastoma (author's transl)].
    Saito K; Tamada K; Nishimura Y; Yamabe H; Koori Y; Inatome T; Fujiwara T; Katayama K; Morikawa H
    Nihon Naika Gakkai Zasshi; 1982 Mar; 71(3):331-9. PubMed ID: 6286811
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endocrinological study of arrhenoblastoma].
    Nishimura T; Yoshida Y; Sugimoto O; Mori M; Inohara T
    Sanfujinka No Jissai; 1969 Aug; 18(8):747-58. PubMed ID: 4310780
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma testosterone in hirsute women: diagnostic significance of stimulation-suppression tests.
    von Werder K; Ettinger B; Thenaers GC; Forsham PH
    Acta Endocrinol Suppl (Copenh); 1971; 152():16. PubMed ID: 5313534
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of plasma testosterone and 5-dihydrotestosterone in hirsutic women using the dexamethasone-HCG-test].
    Haeffele R; Elsaesser F; Haller J; König A
    Fortschr Androl; 1974; 3():91-3. PubMed ID: 4469555
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct in-vivo detection of atypical hormonal expression of a Sertoli-Leydig cell tumour following stimulation with human chorionic gonadotrophin.
    Cohen I; Shapira M; Cuperman S; Goldberger S; Siegal A; Altaras M; Beyth Y
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):491-5. PubMed ID: 8287578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.